Author/Authors :
Zhou، نويسنده , , Bisheng and Ma، نويسنده , , Ruihua and Si، نويسنده , , Wenxia and Li، نويسنده , , Sisi and Xu، نويسنده , , Yan and Tu، نويسنده , , Xin and Wang، نويسنده , , Qing، نويسنده ,
Abstract :
FGF2 and VEGFA are the two most potent angiogenic factors. Here we report that miR-503 can simultaneously down-regulate FGF2 and VEGFA. The expression of miR-503 is repressed in HCC cells and primary tumors due to a potential epigenetic mechanism. Overexpression of miR-503 reduced tumor angiogenesis in vitro and in vivo. We also found that miR-503 expression was down-regulated by hypoxia through HIF1α. These results identify a miRNA that targets both FGF2 and VEGFA in cancers, demonstrate the anti-angiogenesis role of miR-503 in tumorigenesis, and provide a novel mechanism for hypoxia-induced FGF2 and VEGFA through HIF1α-mediated inhibition of miR-503.
Keywords :
Angiogenesis , miR-503 , FGF2 , Methylation , VEGFA